LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
about
Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells.ASCT2 regulates glutamine uptake and cell growth in endometrial carcinomaNovel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses.Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.
P2860
Q33808162-A8866315-8A12-4306-9A18-79562B899CE9Q38651973-EDE9ECFE-3FDD-4ECD-9D1B-FC7600B7B29DQ39112756-27DDAC49-5F6B-44FE-88B7-10C618F4D498Q41073866-7188DDD8-0614-4366-A8F7-A2E977F73A09Q49365787-BFF47196-C685-4CC5-8561-D0727A3B1C5CQ49627330-1AF7F898-F894-464E-839F-CF2FE1917963Q52563214-F5653E39-142A-42D1-B488-ABF5F728AE05
P2860
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
@en
type
label
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
@en
prefLabel
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
@en
P2093
P2860
P50
P356
P1476
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
@en
P2093
Annora Thoeng
Blake K Zhang
John E J Rasko
Melissa A Vellozzi
Michelle van Geldermalsen
Nicholas J Otte
P2860
P304
P356
10.1002/IJC.30371
P577
2016-08-03T00:00:00Z